OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evidence-based efficacy of methotrexate in adult Crohn’s disease in different intestinal and extraintestinal indications
A. Cassinotti, Alberto Batticciotto, Marco Parravicini, et al.
Therapeutic Advances in Gastroenterology (2022) Vol. 15
Open Access | Times Cited: 10

Showing 10 citing articles:

Procyanidin B2 Mitigates Methotrexate-Induced Hepatic Pyroptosis by Suppressing TLR4/NF-κB and Caspase-3/GSDME Pathways
Juman Alsaab, Wedad S. Sarawi, Ahlam M. Alhusaini, et al.
Food and Chemical Toxicology (2025), pp. 115341-115341
Closed Access

Therapeutic drug monitoring of methotrexate in patients with Crohn's disease
Maartje M. van de Meeberg, Herma H. Fidder, Bas Oldenburg, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 11-12, pp. 1151-1162
Open Access | Times Cited: 13

Systematic review: Methotrexate—A poorly understood and underused medication in inflammatory bowel disease
Léa Sequier, Bénédicte Caron, Damien Lœuille, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 6, pp. 686-700
Closed Access | Times Cited: 2

Immunomodulators: still having a role?
Jeffery M. Venner, Çharles N. Bernstein
Gastroenterology report (2022) Vol. 10
Open Access | Times Cited: 10

Methotrexate accumulation in target intestinal mucosa and white blood cells differs from non‐target red blood cells of patients with Crohn's disease
Maartje M. van de Meeberg, Janani Sundaresan, Marry Lin, et al.
Basic & Clinical Pharmacology & Toxicology (2024) Vol. 135, Iss. 3, pp. 308-320
Closed Access | Times Cited: 1

Management of Crohn’s disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023
Jia‐Feng Wu, Hsu‐Heng Yen, Horng‐Yuan Wang, et al.
Intestinal Research (2024) Vol. 22, Iss. 3, pp. 250-285
Open Access | Times Cited: 1

The Role of Low-Dose Oral Methotrexate in Increasing Anti-TNF Drug Levels and Reducing Immunogenicity in IBD
Kathryn Demase, Cassandra K. Monitto, Robert D. Little, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 13, pp. 4382-4382
Open Access | Times Cited: 3

Effectiveness and tolerability of methotrexate monotherapy in Crohn’s disease patients: a multicenter observational study
Jihye Park, Jaeyoung Chun, Soo Jung Park, et al.
Therapeutic Advances in Gastroenterology (2023) Vol. 16
Open Access | Times Cited: 3

Efficacy of Methotrexate and Anti-TNF Combination Therapy in Adults with Refractory Crohn’s Disease
Paria Boustani, Anahita Sadeghi, Sina Khayatian, et al.
Middle East Journal of Digestive Diseases (2024) Vol. 16, Iss. 4, pp. 221-224
Open Access

Page 1

Scroll to top